Okamoto H, Tsuda F, Akahane Y, Sugai Y, Yoshiba M, Moriyama K, Tanaka T, Miyakawa Y, Mayumi M
Immunology Division, Jichi Medical School, Tochigi-Ken, Japan.
J Virol. 1994 Dec;68(12):8102-10. doi: 10.1128/JVI.68.12.8102-8110.1994.
Hepatitis B virus (HBV) DNA clones were propagated from 57 carriers with antibody to hepatitis B e antigen (HBeAg) and sequenced within nucleotides (nt) 1685 to 1926 including the core promoter (nt 1742 to 1849) and the pre-C region (nt 1814 to 1900). Mutations in the core promoter or those in the pre-C region, or both, were detected in 328 (97.9%) of 335 clones from them. Five carriers were infected with HBV mutants with mutations in the core promoter alone, while 20 carriers were infected only with those in the pre-C region to abort the translation of HBeAg precursor; the remaining 32 carriers were infected with HBV mutants with mutations in both the core promoter and pre-C region. Some carriers infected with HBV with mutations in the core promoter exclusively had high HBV DNA titers, comparable with those in carriers infected with wild-type HBV, thereby indicating that such mutations would not affect the transcription of the HBV pregenome extensively. Two point mutations in the core promoter, from A to T at nt 1762 and from G to A at nt 1764, were most prevalent. The other mutations included a point mutation at either of the two nucleotides and their deletion. All of these mutations involved the TTAAA sequence (nt 1758 to 1762) at 28 bp upstream of the initiation site for shorter pre-C mRNAs (nt 1790 +/- 1). The ATAAATT sequence (nt 1789 to 1795) at 23 bp upstream of the initiation site for the pregenome RNA (nt 1818), however, remained intact in all 335 HBV DNA clones. HBV mutants with mutations in the core promoter, unaccompanied by pre-C mutations, prevailed and replaced wild-type HBV in two carriers as they seroconverted from HBeAg to the corresponding antibody. These results indicate that HBV mutants with an HBeAg- phenotype would be generated by mutations in the core promoter which might abort the transcription of pre-C mRNA but do not seriously affect that of pregenome RNA.
从57名乙肝e抗原(HBeAg)抗体携带者中扩增出乙肝病毒(HBV)DNA克隆,并对1685至1926核苷酸(nt)区域进行测序,该区域包括核心启动子(nt 1742至1849)和前C区(nt 1814至1900)。在来自这些携带者的335个克隆中,有328个(97.9%)检测到核心启动子或前C区或两者的突变。5名携带者感染了仅在核心启动子有突变的HBV突变体,20名携带者仅感染了在前C区有突变的突变体,导致HBeAg前体的翻译终止;其余32名携带者感染了核心启动子和前C区均有突变的HBV突变体。一些仅在核心启动子有突变的HBV携带者具有高HBV DNA滴度,与感染野生型HBV的携带者相当,这表明此类突变不会广泛影响HBV前基因组的转录。核心启动子中的两个点突变最为常见,即nt 1762处的A到T和nt 1764处的G到A。其他突变包括这两个核苷酸中任一个的点突变及其缺失。所有这些突变都涉及较短前C mRNA起始位点(nt 1790 +/- 1)上游28 bp处的TTAAA序列(nt 1758至1762)。然而,前基因组RNA起始位点(nt 1818)上游23 bp处的ATAAATT序列(nt 1789至179 ) 在所有335个HBV DNA克隆中均保持完整。在两名携带者从HBeAg血清学转换为相应抗体时,核心启动子有突变且无前C区突变的HBV突变体占优势并取代了野生型HBV。这些结果表明,具有HBeAg阴性表型的HBV突变体可能由核心启动子突变产生,这些突变可能会终止前C mRNA的转录,但不会严重影响前基因组RNA的转录。